ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
20 Jul 2017 ESMO 2017 Press Release: ESMO Awards recognise four outstanding oncologists
01 Jul 2017 World GI 2017 Press Release: Right-sided Colorectal Tumours: An Internal Radiation Advantage Gastrointestinal cancers
30 Jun 2017 World GI 2017 Press Release: Liquid Biopsies: A Non-invasive Look at Treatment Response Gastrointestinal cancers
30 Jun 2017 World GI 2017 Press Release: Zoning in on Specifics of Mediterranean Diet for Colorectal Health Gastrointestinal cancers
28 Jun 2017 Solange Peters elected ESMO President 2020-2021
15 Jun 2017 Press Release: Annals of Oncology in Top 10 Oncology Journals
15 Jun 2017 World GI 2017 Media Alert: Coming Soon – World’s Largest Gastrointestinal Cancer Congress
13 Jun 2017 ESMO 2019 Press Release: Annual Congress to be held in Barcelona
01 Jun 2017 ESMO 2017 Media Alert: Integrating Science Into Oncology for a Better Patient Outcome
31 May 2017 Press Release: ESMO Welcomes the Adoption of the 2017 WHO Cancer Resolution Bioethics, legal and economic issues
05 May 2017 ELCC 2017 Press Release: Study Shows White Blood Cell Boosting Drugs Safe During Chemo-Radiotherapy of Lung Cancer Lung and other thoracic tumours
05 May 2017 ELCC 2017 Press Release: White Blood Cell Count Predicts Response to Lung Cancer Immunotherapy Epidemiology/Etiology/Cancer Prevention - Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
05 May 2017 ELCC 2017 Press Release: Some Lung Cancer Patients Benefit from Immunotherapy Even After Disease Progression Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
05 May 2017 ELCC 2017 Press Release: Osimertinib Improves Symptoms in Advanced Lung Cancer Patients Lung and other thoracic tumours
04 May 2017 ELCC 2017 Press Release: Patients With Non-Small-Cell Lung Cancer Respond Best to Salvage Chemotherapy When Pre-Treated With PD-1/PD-L1 Inhibitors Lung and other thoracic tumours